QualityStocksNewsBreaks Archives - Page 804 of 1462

WednesdayFeb 17, 2021 9:49 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Provides Update on PowerTap 3G Unit

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has announced additional information regarding PowerTap’s third-generation unit, noting that the unit has increased efficiency and reduced operating costs. The technology and unit are being developed by technology from PowerTap Hydrogen Fueling Corp., an investee company of Clean Power. According to the announcement, the system performance of PowerTap’s third-generation onsite hydrogen production module unit is controlled by advanced operating software with data analytics. Data that is collected through the software is sent through the cloud. Subsequently a data analytics application evaluates the information then deploys advance algorithms to…

WednesdayFeb 17, 2021 9:21 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Shareholder Approval of Canopy Growth Plan of Arrangement

Canopy Rivers (TSX: RIV) (OTC: CNPOF) shareholders have voted to approve the company’s previously announced plan of arrangement regarding Canopy Growth Corporation. Shareholder voting resulted in 99.87% of votes cast by Rivers' shareholders cast in favor of the arrangement; that number included an estimated 99.85% of votes cast by Rivers' shareholders other than Canopy Growth. According to the previously announced arrangement, approval was required from at least two-thirds of the votes cast by the holders of subordinated voting shares as well as two-thirds of votes cast by Canopy Growth and a simple majority of votes cast by holders of SVS…

TuesdayFeb 16, 2021 2:02 pm

QualityStocksNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer

Artelo Biosciences (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways including the endocannabinoid system, today announced the appointment of Andrew Yates, Ph.D, as senior vice president and chief scientific officer. Dr. Yates is an experienced senior pharmaceutical executive, having most recently served at AstraZeneca in significant roles across a number of functional areas including development and commercial strategy, medical affairs and business development. Notably, Dr. Yates has been extensively involved in the life-cycle management of key multi-billion-dollar products including CRESTOR(R), FORXIGA(R) and KEYTRUDA(R). “We are extremely pleased to announce the…

TuesdayFeb 16, 2021 1:22 pm

QualityStocksNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Announces $2.8M Contract Awarded to High Wire Networks

Spectrum Global Solutions (OTCQB: SGSI) has announced that High Wire Networks Inc. was awarded a $2.8 million electrical contract to provide power and fire-alarm infrastructure for new 150,000-square-foot distribution center near Chicago. SGSI previously announced that it had entered into a definitive agreement for a merger with High Wire; the merger, which is anticipated to close within the next few weeks, is subject to specified closing conditions. The multimillion-dollar contract calls for the installation of a 2,500 amps electrical service and infrastructure to power multiple robotic charging stations as well as a large conveyance system at the distribution center, which…

TuesdayFeb 16, 2021 1:12 pm

QualityStocksNewsBreaks – Hollywall Entertainment Inc. (HWAL) Selects IBN as Official Corporate Communications Partner

Hollywall Entertainment (OTC: HWAL), a telecommunications, media, technology, broadcasting and entertainment company, announced that it has chosen InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, to provide its corporate communications. The announcement noted that as part of the partnership, IBN will distribute Hollywall news and communications throughout its comprehensive distribution network of 5,000-plus syndication outlets; IBN will also leverage is wide range of newsletters, social media channels, blogs, and wire services to build and strengthen awareness for Hollywall. Hollywall’s portfolio spans a wide range of industries, including infrastructure development, 5G and telecommunications, broadcasting, education, media and entertainment. Through its development company, Hollywall…

TuesdayFeb 16, 2021 12:59 pm

QualityStocksNewsBreaks – Hunter Technology Corp. (TSXV: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) to Launch Pilot Service Utilizing Blockchain-Based Platform

Hunter Technology (TSXV: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) on Monday announced that it is on track to launch a pilot service for selected customers, including governments, sovereign wealth funds, environmental agencies, regulators and self-regulatory organizations ("users"), in the third quarter of 2021. Per the update, the company is developing its end-to-end service utilizing a proprietary blockchain-based modular software platform to supply users with immutable data intelligence on the full lifecycle of the crude oil supply chain from reserve management through wellhead production, storage, transhipment, export and/or domestic consumption. "Hunter with its technology platform and integration capabilities will support…

TuesdayFeb 16, 2021 12:06 pm

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Licensing Deal with Taste-T LLC

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has announced its licensing deal with U.S. based Taste-T LLC. According to the update, Taste-T utilizes a proprietary manufacturing system to produce and package branded cannabis gummies and sells them in multiple U.S. states including Nevada, Massachusetts, Michigan and Oklahoma. Their famous products come in unique blister packaging and include Margarita Chill and Fireball Cinnamon. Pure Extracts has signed an agreement with exclusive rights for Canada and first rights to other countries around the world. Included…

TuesdayFeb 16, 2021 11:51 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Strategic Expansion of Sales Force

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced a strategic shift to expand its sales team, internalize all account management and transition to a self-service distribution partner in the California adult-use market. To date, PLUS has partnered with full-service distributors, relying on a hybrid of both internal and external personnel to make up its sales force. Under the new self-service model, a member of the PLUS team will own the sales cycle for every order start to finish. “At PLUS, we are focused on bringing customers the best possible experience…

TuesdayFeb 16, 2021 11:13 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that it will present at the upcoming Microcap Rodeo Winter Wonderland Conference. The virtual conference is slated for Feb. 16–19, 2021. AzurRx CEO James Sapirstein is scheduled to make a live company presentation during the conference. The AzurRx presentation is scheduled for 4:30 p.m. ET on Feb. 17. During the presentation, Sapirstein will provide an overview of AzurRx’s business and clinical development programs; he will also talk about milestones anticipated throughout the coming year. Following the presentation, Sapirstein and other AzurRx executives will be…

TuesdayFeb 16, 2021 11:04 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Completion of European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has made a significant announcement, along with its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"). The companies have completed all actions and procedures required for the European regulatory application for the rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR Test System. The announcement noted that ISO 13485 approval for 3a as a medical device manufacturer is expected in the next few weeks; 3a also anticipates European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for COVID-ID Lab by early March. The exclusive lab is designed to be a rapid, accurate and robust test…

Site Search

Company Search

Category: QualityStocksNewsBreaks